20 articles
A meta-analysis of 8 studies finds intermittent fasting significantly reduces liver fat and improves key metabolic markers in MASLD patients.
With 225+ clinical trials behind it, intermittent fasting rivals calorie restriction for type 2 diabetes — yet major guidelines still ignore it.
A systematic review of RCTs finds night fasting windows improve glucose and lipid markers in shift workers, though evidence remains thin.
A new narrative review finds IF activates powerful antioxidant pathways, but warns that clinical proof in humans remains thin and short-term.
A meta-analysis of 4,941 adults finds FTO risk-allele carriers have higher triglycerides on calorie-restricted diets, but most metabolic markers respond similarly across genotypes.
A new review argues that combining GLP-1 receptor agonists with structured exercise and dietary support preserves muscle and delivers lasting fat loss.
A new review maps how tirzepatide's dual GIP/GLP-1 action reshapes metabolism across the pancreas, liver, gut, heart, kidneys, and brain.
Aging adipose tissue loses its ability to generate new fat cells, driving insulin resistance. New review maps the molecular culprits and best treatment options.
A new framework reveals how lactate and β-hydroxybutyrate team up across organs to regulate metabolism, mitochondria, and disease.
Longevity experts endorse short CGM trials for non-diabetics, but RCT evidence remains thin. Here's what the data actually shows.
Longevity experts endorse CGMs for metabolic optimization, but RCT evidence in non-diabetics is still thin.
A Cochrane review of 37 RCTs finds obesity drugs modestly reduce weight in adolescents, but evidence quality is low and long-term data are absent.
Expert reviews compare top CGMs for longevity use, but evidence for healthy adults remains limited. Here's what you need to know.
Continuous glucose monitors are popular in biohacking circles, but direct evidence linking CGM use to extended lifespan remains thin.
A systematic review of 13 studies finds semaglutide and liraglutide meaningfully cut BMI and improve blood sugar in children and adolescents.
Burke and Noakes reach surprising common ground on fueling endurance sport, while key disagreements remain unresolved.
Top longevity doctors endorse CGMs for healthy adults, but evidence is mixed. Here's what the 2026 device reviews reveal.
A head-to-head review of 10 CGM devices for healthy adults, weighing real-world accuracy data against limited longevity evidence.
Dexcom G7 tops expert picks for metabolic biohacking, but evidence for non-diabetics remains mixed. Here's what the data says.
Expert reviews of top CGM platforms reveal genuine metabolic insights — but no proof they extend lifespan in healthy adults.
